Cancer inhibition by green tea
Hirota Fujiki(National Cancer Centre Japan), Kei Nakachi(Saitama Cancer Center), Naoko Sueoka(Saitama Cancer Center), Eisaburo Sueoka(Saga University), Masami Suganuma(Saitama University), Kazue Imai(Saitama Cancer Center), Atsumasa Komori, Sachiko Okabe(Saitama Cancer Center), Kenji Suga(Saitama Cancer Center), Tomoko Kozu(Saitama Cancer Center), Yukiko Tada(Saitama Cancer Center)
Mutation research. Fundamental and molecular mechanisms of mutagenesis
June 1, 1998
Cited by 188
Related Papers
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR
|Journal of Cancer Research and Clinical Oncology|1992|807
Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
|Proceedings of the National Academy of Sciences|1988|602
Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention
|BioFactors|2000|408
Tumor Promotion by Inhibitors of ProteinZ Phosphatases 1 and 2A: The Okadaic Acid Class of Compounds
|Advances in cancer research|1993|310